Butobarbital
Clinical data | |
---|---|
Trade names | Soneryl |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | N05CA03 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
| |
CAS Number | 77-28-1 Y |
PubChem (CID) | 6473 |
DrugBank | DB01353 Y |
ChemSpider | 6229 Y |
UNII | OHZ8QAW6YC Y |
KEGG | D02618 Y |
ChEMBL | CHEMBL404422 Y |
ECHA InfoCard | 100.000.928 |
Chemical and physical data | |
Formula | C10H16N2O3 |
Molar mass | 212.246 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Butobarbital (BAN), also called butobarbitone or butethal, Soneryl, and Neonal,[1] is a hypnotic drug which is a barbiturate derivative. It was developed by Poulenc Brothers (now part of Rhône Poulenc) in 1921.[2]
References
- ↑ International Drug Names
- ↑ DE Patent 481129
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids | |
Imidazoles | |
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
See also: GABAergics |
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.